Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556237 · ClinicalTrials.gov registry record · NA
Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis
A NA study, sponsored by University of Louisville.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07556237 is a NA study that has not yet begun recruiting, run by University of Louisville. The registered enrollment target is 150 participants.
The verdict
NCT07556237, a NA study, has not yet begun recruiting, sponsored by University of Louisville.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Gastroparesis is a disorder characterized by delayed gastric emptying and symptoms including nausea, vomiting, and abdominal pain. Gastric electrical stimulation (GES) using the implanted Enterra™ neurostimulator is FDA-approved to treat nausea and vomiting but its impact on abdominal pain has not been well studied. This study evaluates whether alternative programming parameters of the Enterra™ device can reduce abdominal pain in patients with gastroparesis. Participants with an existing Enterra™ device will be randomized to one of three stimulation settings and followed for assessment of pain, gastrointestinal symptoms, quality of life, and medication use.
Interventions
- DEVICE Enterra™ neurostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07556237
The ClinicalTrials.gov registry entry for NCT07556237 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterra™ neurostimulator is the first listed.
NCT07556237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07556237 about?
NCT07556237 is a clinical study titled "Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis". Gastroparesis is a disorder characterized by delayed gastric emptying and symptoms including nausea, vomiting, and abdominal pain. Gastric electrical stimulation (GES) using the implanted Enterra™ neurostimulator is FDA-approved to treat nausea and vomiting but its impact on abdominal pain has not b...
What is the current status of trial NCT07556237?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-07. Estimated completion is 2030-07.
What interventions are being tested in trial NCT07556237?
The interventions under investigation include: Enterra™ neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT07556237?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.